We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$183B
AUM Growth
-$41.5B
Cap. Flow
-$8B
Cap. Flow %
-4.38%
Top 10 Hldgs %
23.66%
Holding
10,385
New
1,237
Increased
3,761
Reduced
3,800
Closed
1,371

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$783M
2
MS icon
Morgan Stanley
MS
+$518M
3
LOW icon
Lowe's Companies
LOW
+$474M
4
V icon
Visa
V
+$425M
5
NFLX icon
Netflix
NFLX
+$419M

Sector Composition

Rank Sector Weight
1 Financials 5.01%
2 Technology 4.76%
3 Consumer Discretionary 3.82%
4 Industrials 3.81%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCPX
8626
DELISTED
Scorpius Holdings, Inc.
SCPX
$18K ﹤0.01%
+1
New +$42.3K
CTHR
8627
DELISTED
Charles & Colvard Ltd
CTHR
$18K ﹤0.01%
2,160
-1,723
-44% -$15.6K
GENE
8628
DELISTED
Genetic Technologies Ltd.
GENE
$18K ﹤0.01%
1,698
+1,120
+194% +$23.2K
AXU
8629
DELISTED
Alexco Resource Corp
AXU
$18K ﹤0.01%
19,313
-12,034
-38% -$10.9K
NBRV
8630
PUT
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$18K ﹤0.01%
+49
New +$26.3K
MPVD
8631
DELISTED
Mountain Province Diamonds Inc.
MPVD
$18K ﹤0.01%
+12,879
New +$20.2K
SDLP
8632
DELISTED
SEADRILL PARTNERS LLC
SDLP
$18K ﹤0.01%
1,044
-921
-47% -$27K
BYFC icon
8633
Broadway Financial
BYFC
$110M
$17K ﹤0.01%
2,070
+91
+5% +$923
CHCI icon
8634
Comstock Holding Companies
CHCI
$175M
$17K ﹤0.01%
10,257
-2,540
-20% -$5.05K
CLIR icon
8635
ClearSign Technologies
CLIR
$30.6M
$17K ﹤0.01%
+1,707
New +$24.4K
KOPN icon
8636
CALL
Kopin
KOPN
$1.01B
$17K ﹤0.01%
17,000
+7,000
+70% +$12.6K
KOPN icon
8637
Kopin
KOPN
$1.01B
$17K ﹤0.01%
17,478
+2,914
+20% +$5.25K
LPCN icon
8638
Lipocine
LPCN
$17.6M
$17K ﹤0.01%
+766
New +$17.8K
SHIP icon
8639
Seanergy Maritime Holdings
SHIP
$364M
$17K ﹤0.01%
13
+5
+63% +$8.95K
SOL
8640
DELISTED
Emeren Group
SOL
$17K ﹤0.01%
+13,889
New +$23.1K
WHLR
8641
Wheeler Real Estate Investment Trust
WHLR
$337K
0
RNTX
8642
Rein Therapeutics
RNTX
$67.9M
$17K ﹤0.01%
+1,026
New +$41.2K
TCON
8643
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$17K ﹤0.01%
132
+29
+28% +$7.87K
ISEE
8644
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$17K ﹤0.01%
13,900
+1,900
+16% +$3.68K
JRJC
8645
DELISTED
China Finance Online Co., Ltd.
JRJC
$17K ﹤0.01%
+1,898
New +$29.6K
SGYP
8646
CALL
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$17K ﹤0.01%
145,400
-10,200
-7% -$6.69K
BXE
8647
DELISTED
Bellatrix Exploration Ltd.
BXE
$17K ﹤0.01%
+35,997
New +$29.4K
PTX
8648
CALL
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$17K ﹤0.01%
40,700
+12,600
+45% +$7.83K
ABAC
8649
DELISTED
Renmin Tianli Group, Inc. Common Shares
ABAC
$17K ﹤0.01%
+18,093
New +$27.9K
ATHE
8650
Alterity Therapeutics
ATHE
$87M
$16K ﹤0.01%
+1,274
New +$22.1K

Similar funds

Citadel Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Citadel Advisors held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Assurant worth $99.4M.

  • Citadel Advisors's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
  • Citadel Advisors added most to Amazon in Q4 2018, an estimated $1.68B increase.
  • Citadel Advisors's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
  • Citadel Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
  • Citadel Advisors's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
  • Citadel Advisors opened 1,237 new positions and closed 1,371 in Q4 2018.
  • Citadel Advisors's portfolio value fell 19% quarter-over-quarter to $183B.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.